Q/C Technologies, Inc. Amortization of Deferred Charges
Q/C Technologies, Inc. (QCLS) reported Amortization of Deferred Charges of $3.47 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2020-03-25
- Q/C Technologies, Inc. amortization of deferred charges for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Q/C Technologies, Inc. amortization of deferred charges for the quarter ending 2018-09-30 was $0.00.
- Q/C Technologies, Inc. amortization of deferred charges for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Q/C Technologies, Inc. amortization of deferred charges for the quarter ending 2018-03-31 was $3.47K, a 33.33% decline year-over-year.
- Q/C Technologies, Inc. amortization of deferred charges for fiscal 2018 was $3.47K, a 83.56% decline from fiscal 2017.
- Q/C Technologies, Inc. amortization of deferred charges for fiscal 2017 was $21.10K, a 30.01% decline from fiscal 2016.
- Q/C Technologies, Inc. amortization of deferred charges for fiscal 2016 was $30.15K.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month | Amortization of Deferred Charges 9 month | Amortization of Deferred Charges 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $0.00 derived: sum of 2 quarters · filed 2020-03-25 | $0.00 derived: sum of 3 quarters · filed 2020-03-25 | $3.47K 10-K · filed 2020-03-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $3.47K 10-Q · filed 2019-11-14 | $8.79K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $3.47K 10-Q · filed 2019-08-14 | $8.79K derived: sum of 3 quarters · filed 2019-08-14 | $8.71K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $3.47K 10-Q · filed 2019-05-20 | $8.79K derived: sum of 2 quarters · filed 2019-05-20 | $8.71K derived: sum of 3 quarters · filed 2019-05-20 | $19.37K derived: sum of 4 quarters · filed 2019-05-20 |
| 2017-12-31 | $5.32K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $5.24K derived: sum of 2 quarters · filed 2019-04-01 | $15.90K derived: sum of 3 quarters · filed 2019-04-01 | $21.10K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$80.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $10.58K derived: sum of 2 quarters · filed 2018-11-14 | $15.78K 10-Q · filed 2018-11-14 | $21.10K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $10.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $15.86K 10-Q · filed 2018-08-14 | $21.18K derived: sum of 3 quarters · filed 2018-08-14 | |
| 2017-03-31 | $5.20K 10-Q · filed 2018-07-13 | $10.52K derived: sum of 2 quarters · filed 2018-07-13 | ||
| 2016-12-31 | $5.32K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13 | $30.15K 10-K/A · filed 2018-07-13 | ||
| 2016-09-30 | $24.83K 10-Q/A · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |